Literature DB >> 17298984

Histopathological assessment of lymph nodes in upper gastrointestinal cancer: does triple levelling detect significantly more metastases?

Stephen McGrath1, Sarah Cross, Susan Anne Pritchard.   

Abstract

BACKGROUND: For cancers of the upper gastrointestinal tract it is standard to examine one section/level, from paraffin blocks containing lymph node tissue, for metastatic tumour. AIMS: To determine whether significantly more metastases can be detected by assessing two additional levels.
METHODS: 101 archival upper gastrointestinal cancers were evaluated. All negative lymph nodes were examined at two additional levels separated by 100 microm and stained by H&E. The slides were examined for the presence of metastases.
RESULTS: 1143 lymph nodes, that were originally clear of metastases, were examined at a further two levels (three levels in total); 23 additional metastases were identified in 17 patients. Eleven of these patients were already stage N1 before examination of the additional levels. However, six patients were originally N0, and were therefore upgraded to N1.
CONCLUSIONS: Examining lymph nodes at three levels did detect more metastatic deposits than examination of one section/level. In six patients this changed the N stage from N0 to N1. This would have significant prognostic and management implications.

Entities:  

Mesh:

Year:  2007        PMID: 17298984      PMCID: PMC2095474          DOI: 10.1136/jcp.2006.045518

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  18 in total

1.  The prognostic significance of lymph node micrometastasis in patients with esophageal carcinoma.

Authors:  R Incarbone; L Bonavina
Journal:  Cancer       Date:  1999-11-01       Impact factor: 6.860

2.  Clinical implications of lymph node micrometastasis in patients with histologically node-negative (pN0) esophageal carcinoma.

Authors:  Tsutomu Nakamura; Hiroko Ide; Reiki Eguchi; Kazuhiko Hayashi; Masaho Ota; Ken Takasaki
Journal:  J Surg Oncol       Date:  2002-04       Impact factor: 3.454

3.  Lymph node-based prognostics: limitations with individualized cancer treatment.

Authors:  Wayne S Kendal
Journal:  Am J Clin Oncol       Date:  2006-06       Impact factor: 2.339

4.  Clinicopathologic factors correlated with number of metastatic lymph nodes in oesophageal cancer.

Authors:  M Tachibana; H Yoshimura; S Kinugasa; D K Dhar; M Shibakita; S Ohno; S Ueda; T Fujii; N Nagasue
Journal:  Dig Liver Dis       Date:  2001-10       Impact factor: 4.088

5.  Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western world.

Authors:  J R Siewert; H J Stein; M Feith; B L Bruecher; H Bartels; U Fink
Journal:  Ann Surg       Date:  2001-09       Impact factor: 12.969

6.  Lymph node micrometastasis and prognosis in patients with oesophageal squamous cell carcinoma.

Authors:  F Sato; Y Shimada; Z Li; G Watanabe; M Maeda; M Imamura
Journal:  Br J Surg       Date:  2001-03       Impact factor: 6.939

7.  Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients.

Authors:  J Rüdiger Siewert; M Feith; M Werner; H J Stein
Journal:  Ann Surg       Date:  2000-09       Impact factor: 12.969

8.  Prognostic significance of the carcinoma area in the thickest part of the lymph node.

Authors:  N Doi; T Imada; N Aoyama; Y Kameda; H Koizumi
Journal:  Hepatogastroenterology       Date:  2000 May-Jun

9.  Frequency and clinical impact of lymph node micrometastasis and tumor cell microinvolvement in patients with adenocarcinoma of the esophagogastric junction.

Authors:  J D Mueller; H J Stein; T Oyang; S Natsugoe; M Feith; M Werner; J Rüdiger Siewert
Journal:  Cancer       Date:  2000-11-01       Impact factor: 6.860

10.  Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status.

Authors:  Mohamad A Eloubeidi; Renee Desmond; Miguel R Arguedas; Carolyn E Reed; C Mel Wilcox
Journal:  Cancer       Date:  2002-10-01       Impact factor: 6.860

View more
  4 in total

1.  Feasibility study of sentinel lymph node biopsy in esophageal cancer with conservative lymphadenectomy.

Authors:  Sarah K Thompson; Dylan Bartholomeusz; Peter G Devitt; Peter J Lamb; Andrew R Ruszkiewicz; Glyn G Jamieson
Journal:  Surg Endosc       Date:  2010-08-20       Impact factor: 4.584

2.  Utility of the one-step nucleic acid amplification assay in sentinel node mapping for early gastric cancer patients.

Authors:  Ayako Shimada; Hiroya Takeuchi; Tomohiko Nishi; Shuhei Mayanagi; Kazumasa Fukuda; Koichi Suda; Rieko Nakamura; Norihito Wada; Hirofumi Kawakubo; Tadaki Nakahara; Kaori Kameyama; Yuko Kitagawa
Journal:  Gastric Cancer       Date:  2019-10-30       Impact factor: 7.370

3.  Sentinel lymph node biopsy in esophageal cancer: should it be standard of care?

Authors:  Sarah K Thompson; Dylan Bartholomeusz; Glyn G Jamieson
Journal:  J Gastrointest Surg       Date:  2011-08-02       Impact factor: 3.452

4.  Multicenter study evaluating the clinical performance of the OSNA assay for the molecular detection of lymph node metastases in gastric cancer patients.

Authors:  Koshi Kumagai; Noriko Yamamoto; Isao Miyashiro; Yasuhiko Tomita; Hitoshi Katai; Ryoji Kushima; Hitoshi Tsuda; Yuko Kitagawa; Hiroya Takeuchi; Makio Mukai; Masayuki Mano; Hidetaka Mochizuki; Yo Kato; Nariaki Matsuura; Takeshi Sano
Journal:  Gastric Cancer       Date:  2013-06-07       Impact factor: 7.370

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.